Impact of COVID-19 on Economy, Industry and Company :
The emergence of novel coronavirus has affected the global economy, industry dynamics and company’s top line. The entire ecosystem has to suffer the impact of this pandemic disease which would result in significant demand & supply gap, production delay and weak consumer demand of end products across industries. At Bizizz Market Research, our analyst has done extensive research across industries and identify various methodologies which would assist C-Level executive to counter this ongoing threat and make informed business decision.
Kindly contact us to know more details: https://www.bizizzmarketresearch.com/contact
Global Tissue Microarray Market was Valued at US$ XX Bn in 2019 and it is Expected to Reach More than US$ 12.01 Bn by 2028, Likely to Grow with the CAGR of 10.5% During the Forecast Period
Tissue microarray is an important-output technology which stimulates and expedites on-site examination of tissue. The identification of the condition-creating gene is a significant center in the modern high-level biomedical analysis. Array-originated technology gives a program for molecular outlining of abnormal tissue and genes such as tissue array and DNA array. Thousands of genes are heretofore recognized by employing microarray technology that may be correlated with ailment beginning, growth, and rise. The recognition of these genes has improved the procedure of lead discovery. Scientific assessment of such leads is a difficult job as it requires the study of various well-defined tissue specimens. Tissue microarray helps in examining the thousands of tissue specimens concurrently in working array setup. The procedure of tissue microarray assists to sustain the speed with the lead discovery procedure.
Increasing Utilization Of Tissue Microarray In Medicine Development, Rising Frequency Of Malignancy (Cancer), And The Growing Necessity For Cost-Efficient And Precise Distinguishing Methods Are Driving The Demand For Tissue Microarray Across The Globe
The pervasiveness of cancer is one of the vital factors that drive the expansion of the tissue microarray market. As stated by the American Cancer Society, approximately 13 % of all cancers detected in grown-ups were 20 years old. It further specified that the percentage of thyroid cancer, liver cancer, and Skin cancer are swelling from the previous few years. As said by, Centers for Disease Control and Prevention (CDC) the US breast cancer data, approximately 1 in 8 US women will grow intrusive breast cancer during the course of their lifespan. This situation consequently boosts the tissue microarray market.
Furthermore, rising improvements in biotechnology and pharmaceutical organizations and inflating requirement for cost-efficient and precise diagnostic procedures have propelled the augmentation of the market. In addition, the upsurge in the practice of microarrays in numerous purposes is an additional factor estimated to boost the market evolution in the course of the assessment period. In the previous few years, the application of DNA centered microarrays has become the process of selection for assessing gene expression. This is primarily accredited to factors like complications and expense lessening enabling the technology to be more reachable and uniform.
Factors like an increase in the number of circumstances of tumor sufferer in consort with high-tech improvements and enactment of microarray procedure in proteomic and genomic filed as a result of its regularity in result, fast assay, fewer sample demand are forecasted to expand the increment of the tissue microarray market.
Nevertheless, tissue microarray may not be profitable for heterogeneous cancers, which is anticipated to restrain the development of the market. Technological limitations like lower tissue yield because of the difference in donor block wideness and others are restrictions on the market.
According to product type, the market is classified into embedded tissue array, tissue array slides, frozen tissue array, paraffin cell line array, and others. The paraffin entrenched tissue array subdivision is assessed to lead the market for the duration of the evaluation period.
Moreover, by the application type, the market is categorized into in situ hybridization, FISH, nucleic acid extraction, mRNA, immunohistochemistry, and others. The immunohistochemistry and in situ hybridization subdivisions are expected to hold substantial market portions in the near future as a result of an upsurge in the implementation of protein expression procedure for analysis of ailment.
Depending upon the end-user category, the market is divided into clinics, diagnostic centers, hospitals, and others. The hospital subdivision estimated for the largest market share. This subdivision is assessed to carry on with its supremacy registering a higher CAGR over the valuation interval. The procedure of tissue microarray is exceedingly accurate and necessitates a trained person to manage and examine the output statistics. Thus, the market for the hospital is anticipated to witness high growth in the duration of the evaluation period.
North America Held A Key Share In Global Tissue Microarray Market In 2019
North America is assessed to lead the tissue microarray market in the duration of the evaluation period. This is ascribed to the upsurge in the occurrence of malignancy in the region, heading to the necessity for tissue microarrays. In addition, growing utilization in medication detection is also accountable for the evolution of the market.
Europe secures the second position in the market following the North American region. Augmenting focus on fast analysis and therapy of cancer and contagious disorders, variation in lifestyle, and a large prevalence of cancer amongst older persons propel this market in the European region.
Furthermore, the Asia-Pacific region is anticipated to be the rapidly escalating market for tissue microarray. The swelling pervasiveness of cancer, consciousness amongst the people about their health, and fluctuating lifestyle assist to the progress of this market.
The major players operating in the Tissue Microarray market are Applied Microarrays, Illumina, Inc., Arrayit, Merck Sharp & Dohme Corp, Protein Biotechnologies Inc., Pantomics Inc., Takara Bio, Perkin Elmer, Phalanx Biotech, QIAGEN, Asterand Bioscience, and Agilent Technologies.
Global Tissue Microarray Market, by Procedure
- Frozen Tissue Array
- Fluorescent in Situ Hybridization
Global Tissue Microarray Market, by Technology
- Western Blotting
- Northern Blotting
- Next-Generation Sequencing
- DNA Microarray
- Polymerase Chain Reaction (PCR)
Global Tissue Microarray Market, by Application
- Sequencing Bioinformatics
- Comparative Genomic Hybridization
- Double-Stranded B-DNA Microarrays
- SNP Detection
- Gene Expression Profiling
Global Tissue Microarray Market, by End-user
- Research Organization
- Pharmaceutical and Biotechnological Companies
Global Tissue Microarray Market, by Region
- North America
- Asia Pacific
- Latin America
- Middle East and Africa